S hares of KALA BIO (KALA) have been struggling lately and have lost 17.1% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that ...
ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback